S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS

Bibliographic Details
Published in:	HemaSphere
Main Authors:	Gili Kenet, Beatrice Nolan, Bulent Zulfikar, Bulent Antmen, Peter Kampmann, Tadashi Matsushita, Chur-Woo You, Kateryna Vilchevska, Catherine N. Bag, Azizan Sharif, Flora Peyvandi, Guy Young, Claude Negrier, Christian Sussebach, Fadi Shammas, Shauna Andersson, Baisong Mei, Kaan Kavakli
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968124.64352.6e

Similar Items

S301: CONSUMPTION OF FACTOR CONCENTRATES AND BYPASSING AGENTS FOR MANAGEMENT OF BREAKTHROUGH BLEEDS WITH FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HAEMOPHILIA A OR B: ANALYSIS OF ATLAS-PPX
by: Gili Kenet, et al.
Published: (2023-08-01)

SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE)
by: Guy-Young, et al.
Published: (2024-10-01)

Gene therapy in haemophilia: literature review and regional perspectives for Turkey
by: Kaan Kavaklı, et al.
Published: (2022-07-01)

Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B
by: Steven W. Pipe, et al.
Published: (2025-03-01)

Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia
by: Melek Yıldız, et al.
Published: (2019-06-01)

Evaluation of the interference of fitusiran and antithrombin lowering in plasma on routine coagulation assays
by: Ekta Seth Chhabra, et al.
Published: (2025-08-01)

SURGICAL EXPERIENCE IN PEOPLE WITH HEMOPHILIA A OR B WITH AND WITHOUT INHIBITORS RECEIVING FITUSIRAN
by: Alok-Srivastava, et al.
Published: (2024-10-01)

Validity and reliability of the Turkish version of the Canadian Haemophilia Outcomes-Kids’ Life Assessment Tool (The CHO-KLAT)
by: Ayşe Merve TAT, et al.
Published: (2024-06-01)

Ddp1 Cooperates with Ppx1 to Counter a Stress Response Initiated by Nonvacuolar Polyphosphate
by: Liam McCarthy, et al.
Published: (2022-08-01)

CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran
Published: (2025-10-01)

Evolution of Haemophilia Care in Europe: 10 years of the principles of care
by: D. Noone, et al.
Published: (2020-07-01)

A Novel Molecular Indicator for Inhibitor Development in Haemophilia A
by: Esra Işık, et al.
Published: (2021-06-01)

Haemophilia specialist nurses’ perceptions of haemophilia B
by: Chaplin Steve, et al.
Published: (2021-10-01)

The child with haemophilia
by: C. D. Karabus
Published: (1981-09-01)

The journey of gene therapy in haemophilia – putting the patient at the centre of the hub and spoke model
by: Noone Declan, et al.
Published: (2023-01-01)

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study
by: Christoph Male, et al.
Published: (2020-01-01)

New opportunities in Haemophilia treatment: Efmoroctocog Alfa for patients with Haemophilia A
by: Giovanna Elisa Calabrò, et al.
Published: (2022-01-01)

A New V361A Mutation in <i>Amaranthus palmeri PPX2</i> Associated with PPO-Inhibiting Herbicide Resistance
by: Haozhen Nie, et al.
Published: (2023-05-01)

Hydrocarbons (C8–C12) separation in porous metallocavitand M-PPX (M = Cu, Ag, Au): From computational insight
by: Biswajit Mohanty, et al.
Published: (2023-10-01)

Pulmonary Lobectomy in Haemophilia
by: I. Shoai, et al.
Published: (1972-12-01)

The profile of patients with haemophilia managed at a haemophilia treatment centre in Pretoria, Gauteng
by: Lethukuthula Mafisa, et al.
Published: (2022-10-01)

Distribution of target site PPO-inhibiting herbicide resistance mutations in waterhemp and Palmer amaranth and association of epyrifenacil efficacy with PPX2 target site variants
by: Jacob Montgomery, et al.
Published: (2025-01-01)

Circumcision in haemophilia Moroccan Protocol
by: N. El Ansari, et al.
Published: (2023-01-01)

Haemophilia and access to gene therapy
by: Johnny Mahlangu
Published: (2025-05-01)

AZERBAIJAN EXPERIENCE OF HAEMOPHILIA CARE
by: Gunel Alızada, et al.
Published: (2023-10-01)

Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
by: Kathelijn Fischer, et al.
Published: (2025-05-01)

Feminism Confronts Technology by Judy Wajcman , (Allen and Unwin, North Sydney, 1991) pp.x + 184, $22.95, ISBN 1-86373-100-8
by: Antony Marsh
Published: (1992-11-01)

WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.
by: Manuel Iglesias-Bexiga, et al.
Published: (2015-01-01)

ACQUIRED HAEMOPHILIA A: AN INTRIGUING DISEASE
by: Maria Gabriella Mazzucconi, et al.
Published: (2020-06-01)

Transfusion-Transmitted Infections in Haemophilia Patients
by: Bukurije Zhubi, et al.
Published: (2009-11-01)

Acquired Haemophilia Associated with Urticarial Vasculitis
by: Hassene Attout
Published: (2020-05-01)

POOLED COHORT EQUATIONS RISK SCORE AMONG HAEMOPHILIA: TIME TO FORMALLY EVALUATE CARDIOVASCULAR RISK IN PEOPLE WITH HAEMOPHILIA
by: R.M. Camelo, et al.
Published: (2020-11-01)

Klippel-trenaunay-Weber syndrome with hydronephrosis and vesicoureteral reflux: an unusual association
by: Dinçer Yildizdaş, et al.
Published: (2002-04-01)

Mixed-linker MOF-303 membranes for pervaporation
by: Fang-Hsuan Hu, et al.
Published: (2023-11-01)

Irreversibility of the cell wall modification acts as a limiting factor in desiccation tolerance of Oryza sativa ssp. Indica cv MR303
by: Iqmal Asyraf Ilias, et al.
Published: (2024-06-01)

Scientific Opinion on Flavouring Group Evaluation 303, Revision 1 (FGE.303Rev1): Spilanthol from chemical group 30
by: EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF)
Published: (2015-01-01)

PO44 | Emicizumab in acquired haemophilia A
Published: (2025-10-01)

RENAL ALLOGENEIC TRANSPLANTATION IN PATIENT WITH HAEMOPHILIA B
by: N. V. Purlo, et al.
Published: (2014-12-01)

Case report: Scurvy masquerading as acquired haemophilia
by: Jess Griffin, et al.
Published: (2025-07-01)

Surgery in a Patient with Haemophilia A and Lymphoma
by: M. S. Cruz, et al.
Published: (2020-01-01)